The proposed classification, by the St Gallen International Breast Cancer Conference 2011, into molecular subtypes when routine biomarker analysis by IHC is used as a surrogate for genetic analysis, includes luminal A and B, luminal human epidermal growth factor receptor 2 (HER2), HER2 overexpression, and triple negative (TN) [14]. Here, ERBB2 is linked to breast cancer.